These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26199952)

  • 1. Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient.
    Sato Y; Kobayashi H; Higuchi T; Shimada Y; Era T; Kimura S; Eto Y; Ida H; Ohashi T
    Mol Ther Methods Clin Dev; 2015; 2():15023. PubMed ID: 26199952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.
    Raval KK; Tao R; White BE; De Lange WJ; Koonce CH; Yu J; Kishnani PS; Thomson JA; Mosher DF; Ralphe JC; Kamp TJ
    J Biol Chem; 2015 Jan; 290(5):3121-36. PubMed ID: 25488666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Liver Model of Infantile-Onset Pompe Disease Using Patient-Specific Induced Pluripotent Stem Cells.
    Yoshida T; Jonouchi T; Osafune K; Takita J; Sakurai H
    Front Cell Dev Biol; 2019; 7():316. PubMed ID: 31850350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle.
    Sato Y; Kobayashi H; Higuchi T; Shimada Y; Ida H; Ohashi T
    Mol Ther Methods Clin Dev; 2016; 3():16054. PubMed ID: 27556060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells.
    Yoshida T; Awaya T; Jonouchi T; Kimura R; Kimura S; Era T; Heike T; Sakurai H
    Sci Rep; 2017 Oct; 7(1):13473. PubMed ID: 29044175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification.
    Huang HP; Chen PH; Hwu WL; Chuang CY; Chien YH; Stone L; Chien CL; Li LT; Chiang SC; Chen HF; Ho HN; Chen CH; Kuo HC
    Hum Mol Genet; 2011 Dec; 20(24):4851-64. PubMed ID: 21926084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells.
    Cheng YS; Yang S; Hong J; Li R; Beers J; Zou J; Huang W; Zheng W
    Cells; 2020 Dec; 10(1):. PubMed ID: 33375166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology.
    Sato Y; Kobayashi H; Higuchi T; Shimada Y; Ida H; Ohashi T
    Stem Cells Transl Med; 2017 Jan; 6(1):31-39. PubMed ID: 28170191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.
    Higuchi T; Kawagoe S; Otsu M; Shimada Y; Kobayashi H; Hirayama R; Eto K; Ida H; Ohashi T; Nakauchi H; Eto Y
    Mol Genet Metab; 2014 May; 112(1):44-8. PubMed ID: 24642446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease.
    Piras G; Montiel-Equihua C; Chan YA; Wantuch S; Stuckey D; Burke D; Prunty H; Phadke R; Chambers D; Partida-Gaytan A; Leon-Rico D; Panchal N; Whitmore K; Calero M; Benedetti S; Santilli G; Thrasher AJ; Gaspar HB
    Mol Ther Methods Clin Dev; 2020 Sep; 18():558-570. PubMed ID: 32775491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
    Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
    Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy in pompe disease is not limited to the classic infantile-onset phenotype.
    Lee DH; Qiu WJ; Lee J; Chien YH; Hwu WL
    JIMD Rep; 2014; 17():71-5. PubMed ID: 25213570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell for modeling Pompe disease.
    Huang W; Zhang Y; Zhou R
    Front Cardiovasc Med; 2022; 9():1061384. PubMed ID: 36620633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.
    Douillard-Guilloux G; Richard E; Batista L; Caillaud C
    J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.
    Keeler AM; Zieger M; Todeasa SH; McCall AL; Gifford JC; Birsak S; Choudhury SR; Byrne BJ; Sena-Esteves M; ElMallah MK
    Hum Gene Ther; 2019 Jan; 30(1):57-68. PubMed ID: 29901418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase.
    Puzzo F; Colella P; Biferi MG; Bali D; Paulk NK; Vidal P; Collaud F; Simon-Sola M; Charles S; Hardet R; Leborgne C; Meliani A; Cohen-Tannoudji M; Astord S; Gjata B; Sellier P; van Wittenberghe L; Vignaud A; Boisgerault F; Barkats M; Laforet P; Kay MA; Koeberl DD; Ronzitti G; Mingozzi F
    Sci Transl Med; 2017 Nov; 9(418):. PubMed ID: 29187643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using human Pompe disease-induced pluripotent stem cell-derived neural cells to identify compounds with therapeutic potential.
    Huang HP; Chiang W; Stone L; Kang CK; Chuang CY; Kuo HC
    Hum Mol Genet; 2019 Dec; 28(23):3880-3894. PubMed ID: 31518394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations.
    Wang RY
    Int J Neonatal Screen; 2020 Mar; 6(1):22. PubMed ID: 33073019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease.
    Gal A; Grosz Z; Borsos B; Szatmari I; Sebők A; Jávor L; Harmath V; Szakszon K; Dezsi L; Balku E; Jobbagy Z; Herczegfalvi A; Almássy Z; Kerényi L; Molnar MJ
    Life (Basel); 2021 May; 11(6):. PubMed ID: 34072668
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.